Activity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung cancer.
Sequist
Lecia V
LV
Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. LVSequist@partners.org
Gettinger
Scott
S
Senzer
Neil N
NN
Martins
Renato G
RG
Jänne
Pasi A
PA
Lilenbaum
Rogerio
R
Gray
Jhanelle E
JE
Iafrate
A John
AJ
Katayama
Ryohei
R
Hafeez
Nafeeza
N
Sweeney
Jennifer
J
Walker
John R
JR
Fritz
Christian
C
Ross
Robert W
RW
Grayzel
David
D
Engelman
Jeffrey A
JA
Borger
Darrell R
DR
Paez
Guillermo
G
Natale
Ronald
R